Early Human Development
Volume 86, Issue 2 , Pages 87-92 , February 2010

Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus

Received 14 August 2009 ,Revised 11 December 2009 ,Accepted 30 December 2009.

References 

  1. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2002;3:CD000174
  2. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A, et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007;150:229–234
  3. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics. 2007;119:1165–1174
  4. Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med. 2005;10:177–184
  5. Couser RJ, Hoekstra RE, Ferrara TB, Wright GB, Cabalka AK, Connett JE. Neurodevelopmental follow-up at 36months' corrected age of preterm infants treated with prophylactic indomethacin. Arch Pediatr Adolesc Med. 2000;154(6):598–602
  6. Aranda JV, Thomas R. Systematic review: intravenous Ibuprofen in preterm newborns. Semin Perinatol. 2006;30:114–120
  7. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr. 2005;164:135–140
  8. Safety Survey Report Named Patient Use of Ibuprofen Orphan Europe (PEDEA) Raport IBU/SURVEY/April 2003.
  9. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr. 2002;161:202–207
  10. Morgan AM, Aldag JC. Early identification of cerebral palsy using a profile of abnormal motor patterns. Pediatrics. 1996;98(4 Pt 1):692–697
  11. Brandt I, Sticker E. Griffith Entwicklungsskalen (GES) zur Beurteilung der Entwicklung in den ersten beiden Lebensjahren. 2. erweiterte und überarbeitete Version. Göttingen: Beltz Test-GmbH; 2001.
  12. Bayley N. Bayley scales of infant development (Bsid-II). 3rd ed.. Sydney: Pearson Psychcorp; 1999;
  13. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–1729
  14. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116:1353–1360
  15. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. Arch Ophthalmol. 1987;105:906–912
  16. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500gm. J Pediatr. 1978;92:529–534
  17. Resch B, Vollaard E, Maurer U, Haas J, Rosegger H, Müller W. Risk factors and determinants of neurodevelopmental outcome in cystic periventricular leucomalacia. Eur J Pediatr. 2000;159:663–670
  18. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol. 2000;42(12):816–824
  19. Koehne PS, Bein G, Alexi-Meskhishvili V, Wenig Y, Bührer C, Obladen M. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med. 2001;29:327–334
  20. Ramsay M, Fitzhardinge PM. A comparative study of two developmental scales: the Bayley and the Griffiths. Early Hum Dev. 1977;1(2):151–157
  21. Beail N. A comparative study of profoundly multiply handicapped children's scores on the Bayleys and Griffiths developmental scales. Child Care Health Dev. 1985;11:31–36
  22. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123:e138–e144
  23. Sperandio M, Beedgen B, Feneberg R, Huppertz C, Brüssau J, Pöschl J, et al. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33weeks of gestation. Pediatrics. 2005;116:1361–1366
  24. Jegatheesan P, Ianus V, Buchh B, Yoon G, Chorne N, Ewig A, et al. Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr. 2008;153:183–189
  25. Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol. 2008;65:629–636
  26. Buhrer C, Grimmer I, Metze B, Obladen M. The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth weight infants. Intensive Care Med. 2000;26(3):325–329
  27. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed. 2005;90:F235–F239
  28. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2008;1:CD003481
  29. Rheinlaender C, Helfenstein D, Walch E, Berns M, Obladen M, Koehne P. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants. Acta Paediatr. 2009;98:36–42

PII: S0378-3782(10)00027-7

doi: 10.1016/j.earlhumdev.2009.12.009

Early Human Development
Volume 86, Issue 2 , Pages 87-92 , February 2010

Article Tools

* Image Usage & Resolution